AstraZeneca to seek U.S. approval of COVID vaccine
AstraZeneca said Thursday that it intends to seek U.S. authorization for its COVID-19 vaccine in the second half of this year, offering a new timetable for the much-delayed application.
National drug shortage triggers some heart testing delays in Alberta doctors say
A countrywide shortage of drug used for heart imaging is sparking testing delays for some Alberta cardiology patients.
Comments
Post a Comment